BioCentury
ARTICLE | Clinical News

Rhizen preclinical data

July 1, 2013 7:00 AM UTC

In vitro, 2-7 µM RP6530 led to a >50% dose-dependent inhibition in growth of immortalized T cell lymphoma cell lines. Additionally, 0.5-3 µM RP6530 induced apoptosis in >50% of the cell lines. Data we...



Access The Full Article